交易 | 地址 | 数量 |
---|---|---|
83d58c...ecbc8d
|
the-void |
-
6.2550778 LTC
·
687.05 USD
|
83d58c...ecbc8d
|
LXBjEq...4zn3Zc
|
+
6.2550778 LTC
·
687.05 USD
|
83d58c...ecbc8d
|
script-fac564d11ea7506785b72320529c9775 |
+
0 LTC
·
0.00 USD
|
728ce7...125a16
|
LQ3Ben...oz16hP
|
-
0.1719 LTC
·
18.88 USD
|
728ce7...125a16
|
LSiZ8c...ed2dra
|
-
0.156173 LTC
·
17.15 USD
|
728ce7...125a16
|
LZqeru...FZyRr2
|
+
0.32606091 LTC
·
35.81 USD
|
728ce7...125a16
|
the-void |
+
0.00201209 LTC
·
0.22 USD
|
82d0cc...df1500
|
MWiUYG...G1Yhq3
|
-
85.29025469 LTC
·
9,368.28 USD
|
82d0cc...df1500
|
LQEJ47...ZC6Fi2
|
+
0.96110092 LTC
·
105.56 USD
|
82d0cc...df1500
|
MWiUYG...G1Yhq3
|
+
84.32880277 LTC
·
9,262.67 USD
|
MEI Pharma's stock surged over 33%, raising its market cap to $41.24 million. A strategic transformation led by Titan Partners Group and GSR is pushing MEI Pharma to establish a Litecoin treasury strategy.